Tag:

diabetes

Latest Headlines

Latest Headlines

FDA approves Dexcom smartphone-enabled device for continuous glucose monitor

Dexcom won FDA approval for its next-generation mobile communications device for diabetes monitoring, chalking up another regulatory win and furthering the company's R&D push.

Sanofi, Selecta join hands in diabetes vaccine push

Selecta Biosciences and the Juvenile Diabetes Research Foundation are widening their 2011 research collaboration for a Type 1 diabetes vaccine--and bringing in a little Big Pharma muscle, too.

Stem cell-derived beta cells deliver insulin in response to blood sugar levels

The self-regulation of insulin delivery is a long-sought goal in the field, spurring the development of closed-loop systems and an artificial pancreas for diabetics. But some researchers are aiming smaller, looking at a way to create stem cells en masse that can produce insulin in response to blood sugar levels.

Beyond glucose: developing a diagnostic test for fructose intolerance

Researchers have identified a hormone that is associated with fructose, fibroblast growth factor 21 (FGF21), which increases rapidly in the blood after fructose ingestion. High FGF21 levels in the blood are associated with obesity, insulin resistance and nonalcoholic fatty liver disease in both humans and animals.

Researchers identify blood biomarker to predict diabetes risk

Scientists have discovered a blood biomarker useful in identifying patients at risk for developing diabetes.

Glooko enables wireless smartphone access for existing blood glucose monitors

Glooko has launched a small device that plugs into more than 30 existing blood glucose meters that can transmit data wirelessly to a smartphone, allowing health systems and payers to collect data on their diabetes patients with the monitors they already have.

Homemade medical devices present both challenges and opportunities

Nightscout touts itself as an open source, do-it-yourself project to enable remote monitoring of blood glucose levels of patients with Type 1 diabetes.

Protein Sciences nabs stake in diabetes vax developer Diamyd

With its candidate diabetes vaccine in Phase II combo studies, Diamyd Medical is seeing some new investment--including a bumped-up agreement with longtime partner Protein Sciences.

Sanofi's latest gaming app invites kids on diabetes-fighting mission

When it comes to engaging patients and teaching them to manage their Type 1 diabetes, Sanofi is starting young. The French drugmaker last week rolled out a new app aimed at children, designed to help them share their knowledge about the disease.

Fractyl raises $40M for diabetes treatment via endoscopic surgery

Endoscopic surgery isn't usually associated with diabetes, but Fractyl Laboratories yesterday announced encouraging clinical trial results for its endoscopic procedure to treat Type 2 diabetes and revealed a $40 million Series C financing round led by investment firm Mithril Capital Management.